Predictive model generation for pre-planning a cardiac procedure now reimbursable by Medicare at approximately $1,000 per model
DUBLIN, OH, /January 3, 2024, /EINPresswire.com/ – – Less than six months after earning FDA clearance for its PrecisionTAVI product, DASI Simulations Founder and Chief Technology Officer Dr. Lakshmi (Prasad) Dasi announced today that the Centers for Medicare & Medicaid Services (CMS) has established a new hospital outpatient code and payment level for the Company’s PrecsionTAVI product. “We now have formally procured a reimbursable path for hospitals at a national payment of approximately $1,000 per model generation with each report,” he said. — Read More…